Raquel Ruiz-García

TL;DR: The frequency and distribution of paediatric demyelinating and encephalitic syndromes with MOG antibodies, their response to treatment, and the phenotypes associated with poor prognosis are determined.

TL;DR: Assessment of aPL antibodies in a group of patients with clinical manifestations of APS (C-APS) to evaluate the importance of the presence of IgA aB2GPI antibodies in APS and its relation with other a-PL antibodies.

TL;DR: Patients with LO-NM OSD have similar clinical presentation but worse outcome than EO-NMOSD when they are double seronegative or AQP4-IgG positive, and Serostatus and residual disability after first attack are the main predictors of LO- NMOSD outcome.

TL;DR: Findings show a robust diagnostic value of combined diagnostic techniques, and both should be used to demonstrate onconeural antibodies, if antibody testing is performed only with line blot assay, positive bands should be confirmed by rodent brain immunohistochemistry.

TL;DR: The fact that the levels of pro-inflammatory cytokines do not predict the long-term functional outcome suggests that the prognosis is more related to neuronal damage than to the acute neuroinflammatory process.